Matches in Wikidata for { <http://www.wikidata.org/entity/Q87255051> ?p ?o ?g. }
- Q87255051 description "artículu científicu espublizáu en mayu de 2015" @default.
- Q87255051 description "im Mai 2015 veröffentlicher wissenschaftlicher Artikel" @default.
- Q87255051 description "scientific article published on 07 May 2015" @default.
- Q87255051 description "wetenschappelijk artikel" @default.
- Q87255051 description "наукова стаття, опублікована в травні 2015" @default.
- Q87255051 name "BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional," @default.
- Q87255051 name "BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional," @default.
- Q87255051 type Item @default.
- Q87255051 label "BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional," @default.
- Q87255051 label "BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional," @default.
- Q87255051 prefLabel "BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional," @default.
- Q87255051 prefLabel "BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional," @default.
- Q87255051 P1433 Q87255051-B0EC3971-5C13-4F13-AFA4-F4DF92D96E69 @default.
- Q87255051 P1476 Q87255051-07DF8DE8-8549-4459-9825-26B3CA4CB9BB @default.
- Q87255051 P2093 Q87255051-18F8B65F-55C6-4895-BF9B-FDA90ADAADC3 @default.
- Q87255051 P2093 Q87255051-2061D8CC-6EF9-4662-B663-BF703C657C2E @default.
- Q87255051 P2093 Q87255051-27EEF908-D28D-4143-9B4E-EACC2E343F97 @default.
- Q87255051 P2093 Q87255051-347B7CAB-6658-4A19-B997-B78A4E68A8CC @default.
- Q87255051 P2093 Q87255051-54DDFAE0-176B-4B89-8550-F74CB9912ACE @default.
- Q87255051 P2093 Q87255051-726092A7-B268-41E0-AF16-E50411340A51 @default.
- Q87255051 P2093 Q87255051-80457554-37DC-44BD-8E9A-02E9059006CD @default.
- Q87255051 P2093 Q87255051-A5B3E921-D8F6-4DED-82DB-2A063308B683 @default.
- Q87255051 P2093 Q87255051-AB805889-3900-4C81-BE83-F96B45082BAB @default.
- Q87255051 P2093 Q87255051-D803D4DC-7158-4329-82A9-CB607B804A22 @default.
- Q87255051 P2093 Q87255051-E72F3069-2AAE-4B05-8F21-1433D5C0CC25 @default.
- Q87255051 P2093 Q87255051-ECE8DDBF-80C0-4556-808D-539293ABB788 @default.
- Q87255051 P2093 Q87255051-F8CA73D8-5830-4E13-9B36-C05BDE5AC185 @default.
- Q87255051 P2860 Q87255051-0CDE8A93-821C-40A1-96F9-53C4FB13C5B6 @default.
- Q87255051 P2860 Q87255051-11B45EE8-C33D-47A0-80C6-E070F3FD4001 @default.
- Q87255051 P2860 Q87255051-1A7A4DB1-DFE2-4754-BC22-7D0DE9117470 @default.
- Q87255051 P2860 Q87255051-2D1B8A69-3EB2-45CE-9E7F-3339ED43FD22 @default.
- Q87255051 P2860 Q87255051-3CEE6444-0EB1-43CA-A8EE-F6F00784A5A9 @default.
- Q87255051 P2860 Q87255051-4CF6F561-0415-481A-82CD-BE1612B22B99 @default.
- Q87255051 P2860 Q87255051-4E1534F1-74F7-4064-A66E-FBF0D021E678 @default.
- Q87255051 P2860 Q87255051-51B0D93B-4934-4C14-8B3E-08939AD8A541 @default.
- Q87255051 P2860 Q87255051-5AAC2EA9-4430-4803-BCC6-C38BA817854D @default.
- Q87255051 P2860 Q87255051-63582D75-F672-479D-BAE4-A5F6A8EDAED5 @default.
- Q87255051 P2860 Q87255051-67B7C55D-1F56-4803-BED4-9D0F896A1943 @default.
- Q87255051 P2860 Q87255051-7D2CFC8F-26EE-4CC6-B659-287237EB70EC @default.
- Q87255051 P2860 Q87255051-869A138C-377C-4AFC-A832-51EC1AF30C13 @default.
- Q87255051 P2860 Q87255051-8AEC1998-0F23-4E3D-BEA8-723E9E799BA6 @default.
- Q87255051 P2860 Q87255051-95714909-94E0-403D-BF79-9054D1FD8939 @default.
- Q87255051 P2860 Q87255051-9ED8358A-CEAD-42C7-B0E8-A0C082839AE9 @default.
- Q87255051 P2860 Q87255051-A283EE45-260F-4D15-A527-25F317536221 @default.
- Q87255051 P2860 Q87255051-A467432D-32B0-4260-877D-463722D73E70 @default.
- Q87255051 P2860 Q87255051-B6278206-603A-42F8-B5A9-F548B3C761A7 @default.
- Q87255051 P2860 Q87255051-B6898E4B-F1E4-4559-8C93-011733D379E6 @default.
- Q87255051 P2860 Q87255051-B8752AC3-9B13-49D4-9918-5B9D0A5EF1F0 @default.
- Q87255051 P2860 Q87255051-B8B51357-3FCF-4B2B-9F4D-8DE41D0A4C8F @default.
- Q87255051 P2860 Q87255051-EC4DD2D1-722A-45DF-B337-E7FE05CA9AA5 @default.
- Q87255051 P2860 Q87255051-EF4E90AA-B02D-4716-8D59-0EC1E7422C2C @default.
- Q87255051 P304 Q87255051-55031165-C202-4767-85B0-A032C0D49AE8 @default.
- Q87255051 P31 Q87255051-D1B3779F-3BD4-4A06-8AF4-5D3C8D11A6B2 @default.
- Q87255051 P356 Q87255051-7295502B-604E-4CD1-8B26-C9702E350197 @default.
- Q87255051 P433 Q87255051-77FAFE08-1F47-4D4A-A1D3-D568613D79B2 @default.
- Q87255051 P478 Q87255051-2EE6D721-BCC0-416C-AD8F-F040936D6B3D @default.
- Q87255051 P50 Q87255051-E7702F75-84DE-4911-8AE0-60D95098F374 @default.
- Q87255051 P577 Q87255051-D1C58D4E-660A-4A30-8BAE-EEE51D5017E6 @default.
- Q87255051 P698 Q87255051-77CEA82E-0CF8-418C-97D7-47FCF3FAE619 @default.
- Q87255051 P921 Q87255051-E3842368-64B7-4EE0-A930-CEB915D8B8A6 @default.
- Q87255051 P356 S11060-015-1793-2 @default.
- Q87255051 P698 25947286 @default.
- Q87255051 P1433 Q15752119 @default.
- Q87255051 P1476 "BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial" @default.
- Q87255051 P2093 "Anthony L Asher" @default.
- Q87255051 P2093 "Ashley L Sumrall" @default.
- Q87255051 P2093 "Brent E Heideman" @default.
- Q87255051 P2093 "Brian D Blaker" @default.
- Q87255051 P2093 "H James Norton" @default.
- Q87255051 P2093 "James T Symanowski" @default.
- Q87255051 P2093 "Kevin Judy" @default.
- Q87255051 P2093 "Lynn Ashby" @default.
- Q87255051 P2093 "Peggy Boltes" @default.
- Q87255051 P2093 "Renee Kelly" @default.
- Q87255051 P2093 "Roshan S Prabhu" @default.
- Q87255051 P2093 "Stuart H Burri" @default.
- Q87255051 P2093 "Wendy Brick" @default.
- Q87255051 P2860 Q24683819 @default.
- Q87255051 P2860 Q27860910 @default.
- Q87255051 P2860 Q28216788 @default.
- Q87255051 P2860 Q28360996 @default.
- Q87255051 P2860 Q29547224 @default.
- Q87255051 P2860 Q33382214 @default.
- Q87255051 P2860 Q33394021 @default.
- Q87255051 P2860 Q34116001 @default.
- Q87255051 P2860 Q35845231 @default.
- Q87255051 P2860 Q35894943 @default.
- Q87255051 P2860 Q37278379 @default.
- Q87255051 P2860 Q37846215 @default.
- Q87255051 P2860 Q38557135 @default.
- Q87255051 P2860 Q38559185 @default.
- Q87255051 P2860 Q40817780 @default.
- Q87255051 P2860 Q43073828 @default.
- Q87255051 P2860 Q43759942 @default.
- Q87255051 P2860 Q43964349 @default.
- Q87255051 P2860 Q44781447 @default.
- Q87255051 P2860 Q44838622 @default.
- Q87255051 P2860 Q44999721 @default.
- Q87255051 P2860 Q46529448 @default.
- Q87255051 P2860 Q46947774 @default.